News

ProVen Growth and Income VCT PLC Announces New Dividend Plans

ProVen Growth and Income VCT PLC Announces New Dividend Plans

ProVen Growth and Income VCT PLC Announces Dividend Plans

ProVen Growth and Income VCT PLC has declared an interim dividend for the financial year ending soon, reflecting the company’s commitment to providing returns to its shareholders. The Board is excited to announce a dividend of 1.25 pence per share, a decision that highlights their confidence in the company’s financial performance.

Details of the Dividend Payment

The dividend is set to be paid on a specified date, with all eligible shareholders receiving their earnings according to the established register. It’s crucial for shareholders to mark this date on their calendars and ensure they are on the register by the given deadline to benefit from this financial distribution.

Key Dates to Remember

The dividend payment will occur on 17 January, a date that can be significant for shareholders looking to understand the timing of their returns. Being on the register by 20 December is essential to ensure the payment is received without any issues.

Why This Dividend Matters

Dividends are an important aspect of investing, especially for those who rely on regular income from their investments. The decision to issue a dividend reflects ProVen Growth and Income VCT PLC's ongoing strategy to enhance shareholder value and maintain a strong relationship with investors. This move demonstrates their ability to generate sustainable profits and indicates a promising outlook for future financial performance.

The Implications for Shareholders

For current and prospective investors, this dividend announcement may impact their investment strategies. Understanding the implications of dividend declarations can help investors make informed decisions. Received dividends can be reinvested or withdrawn, providing flexibility depending on individual financial goals.

Contact Information for More Details

For shareholders seeking further information regarding the dividend or any other inquiries related to ProVen Growth and Income VCT PLC, they can easily reach out to the company’s secretary. Beringea LLP is the point of contact for any questions. Investors are encouraged to use the contact number provided to ensure they get accurate and timely information.

Company Secretary Contact

Should you have questions or need assistance, you can contact Beringea LLP at 020 7845 7820. Having direct access to company officials enhances transparency and helps maintain a strong relationship between the company and its shareholders.

Frequently Asked Questions

What is the dividend amount declared by ProVen Growth and Income VCT PLC?

The declared interim dividend is 1.25 pence per share for the financial year ending 28 February.

When will the dividend be paid to shareholders?

The dividend payment is scheduled for 17 January.

What should shareholders do to receive the dividend?

Shareholders must be on the register by 20 December to qualify for the dividend payment.

Who can I contact for more information about the dividend?

For more details, shareholders can contact Beringea LLP at 020 7845 7820.

Why are dividends important for investors?

Dividends provide a return on investment and can be reinvested or withdrawn, making them an essential part of investment strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

China-CEEC Forum Sparks Robust SME Partnerships

Updated Category News Views 67

There’s a fresh buzz around Cangzhou's efforts to galvanize business opportunities between China and Central and Eastern Europe. The 7th China-CEEC SME Forum, kicking off in this city of Hebei Province, isn’t just another meeting of the minds. Nope, it’s like a marketplace thrown into overdrive—where AI strategies and logistics are shaping up to be the star...

Continue Reading
Memoir 'Pinball' Explores Life's Unpredictable Momentum

Updated Category News Views 91

Funny how some folks think life has a road map. Let me tell you, it's more like a pinball machine, barely controllable and ready to surprise you with a tilt at any moment. And that's the essence of Marshall Barber's new memoir, 'PINBALL: Remembrances of a Flaneur.' Life's Roulette: Choices and Chance Barber takes readers on a raw ride through the byways of a life...

Continue Reading
Montefiore Einstein Takes On Breast Cancer's Hidden Battle

Updated Category News Views 11

Call me old-fashioned, but when cancer whispers in the shadows even after it's supposedly signed off the death certificate, you're dealing with one heck of a slippery adversary. That's where Montefiore Einstein Comprehensive Cancer Center comes in, armed with ten million greenbacks from the National Cancer Institute, primed to rattle the labyrinth of breast cancer...

Continue Reading
LUX Infusion Expands in Nebraska with New Acquisitions

Updated Category News Views 130

Strategic Expansion: LUX Infusion's Bold Move When it comes to healthcare, it's often about pulling the right strings at the right time, and today, LUX Infusion's got their timing spot on. They've swooped in with a savvy acquisition, taking over two key specialty infusion centers in Lincoln and Omaha. This isn't just a pencil-pusher's cynical corporate move; it's a push...

Continue Reading
Syra Health Hits Record Revenue, Sustains Growth

Updated Category News Views 89

Syra Health Reports Stellar Q3 Performance Folks, let's dive right into the figures: Syra Health's Q3 2026 performance is nothing short of a powerhouse display. We're talking about a jaw-dropping 52% surge in revenue compared to the same period last year, climbing to a record $2.6 million. It's not often you see a company swing its EPS from a loss of $(0.02) to a positive...

Continue Reading
ALS Research Gains Momentum as ACT for ALS Law Signed

Updated Category News Views 42

A Major Stride in ALS Advocacy Today's not your usual day at the office for the folks championing the fight against ALS. With the President putting pen to paper, the ACT for ALS Act just turned into law, sending ripples through the community. Let me tell ya, legislation like this doesn't float by on a cloud—it's the result of grit, sleepless nights, and a dash of...

Continue Reading
Mothers® Revamps Ceramic Care with New Detailer

Updated Category News Views 50

A Game-Changer in Ceramic Care If you've ever wrestled with ceramic coatings, you know it's not the easiest gig. But here's Mothers® pulling a rabbit out of their hat at the 2026 SEMA Show with this new gadget—a Ceramic Instant Detailer—and let me tell you, it's a breath of fresh air for car enthusiasts. Standing tall with its SiO?-enhanced charm, this stuff promises...

Continue Reading
Minghui and ASKA Seal Major Licensing Deal for MHB018A

Updated Category News Views 10

Breaking New Ground in Thyroid Eye Disease Treatment If there's one thing that keeps the biopharma world on its toes, it's the relentless pursuit of groundbreaking treatments. And folks, let me tell you, the latest tie-up between Minghui Pharmaceutical and ASKA Pharmaceutical has struck a chord. This union with MHB018A at its core might be one of those watershed moments...

Continue Reading
EX.CO Lands Spot on Duns 100 Best Companies List

Updated Category News Views 31

The tech world doesn't stop for anyone, and EX.CO seems to be riding the front of this speeding train. Cracking the top 20 of the Duns 100 list, EX.CO's snagged the 18th spot in the competitive startup category, proving their mettle in the business of transforming screens into revenue juggernauts. Riding the AI Wave In a world where AI is rewriting scripts faster than any...

Continue Reading
Quarterhill's Q3 2026 Call Teases Insight into ITS Growth

Updated Category News Views 38

The clock's ticking down to November 10, and eyes are peeled for Quarterhill's Q3 financial debrief. Why the fuss? Well, they’ve made quite a name for themselves in the Intelligent Transportation System (ITS) scene, tossing AI into the mix to boot. If you’re playing in this space—or just sneaking a peek to see where tech’s steering us next—you might want to dial...

Continue Reading

Top 5 Most Recently Viewed Articles

Operation HOPE Celebrated for Transformational Community Impact

Updated Category News Views 194

Operation HOPE Recognized as a Top Nonprofit Operation HOPE, a key player in financial literacy and economic inclusion, has earned recognition as one of Atlanta's top nonprofit organizations. This accolade reflects the strong financial health, mission clarity, and effective leadership within the organization, marking HOPE's consistency in ranking 17th among nearly 45,000...

Continue Reading
US Regulators' Stand on Crypto: A Cautious Approach Unveiled

Updated Category News Views 126

US Regulators' Approach to Cryptocurrency Activities A recent analysis of documents released by a U.S. bank regulator sheds light on the cautious stance taken regarding banks' involvement in the cryptocurrency sector. This examination reveals that while numerous lenders were advised to pause any direct engagements with cryptocurrencies in recent years, they were not...

Continue Reading
Concerns Arise as Atkore Inc. Faces Class Action Investigation

Updated Category News Views 288

Concerns Arise for Atkore Inc. Shareholders The recent developments surrounding Atkore Inc. have raised significant concerns among investors, particularly for those who have held shares during the designated class period. Allegations of illegal practices that potentially inflated stock prices are at the forefront of this ongoing investigation. Class Action Investigation...

Continue Reading
Boost Your Wellness Journey with Gundry MD's MCT Wellness

Updated Category News Views 445

Transform Your Health with Gundry MD® MCT Wellness® Every year, health enthusiasts come together to celebrate World Health Day, embracing the opportunity to enhance well-being. This year, Gundry MD® is excited to spotlight MCT Wellness®, a product designed to align perfectly with health-conscious lifestyles. Known for its nourishing perks, MCT Wellness® has garnered...

Continue Reading
Yannick Fierling's Nomination to AB Electrolux Board

Updated Category News Views 144

Election Proposal for Yannick Fierling to Join Board The Nomination Committee of AB Electrolux has put forth the proposal to elect Yannick Fierling, the current President and CEO, as a new member of the Board of Directors at the forthcoming Annual General Meeting. This proposal comes as part of a broader restructuring within the Board. Leadership Transition at AB...

Continue Reading